Covid-19: Joint statement from the ABS & UKBCG on Neoadjuvant Chemotherapy

The UKBCG and ABS released a joint statement on neoadjuvant chemotherapy during the Covid-19 pandemic

ABS & UKBCG | UK
15.05.2020

Added: 15.05.2020

Classifications: Service Guidance

Keywords: Neoadjuvant Chemotherapy/ NACT COVID-19